Warm Needling Moxibustion at Tianshu and Guanyuan Acupoints for Yang Deficiency Type Chronic Functional Constipation
This study aims to treat Yang Deficiency type chronic functional constipation by using warm needling moxibustion at Tianshu and Guanyuan acupoints, with the primary goal of improving your Constipation Severity Score (CSS) at week 4 and month 6.
Warm Needling
+ Electroacupuncture
Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
+ Yang Deficiency
Treatment Study
Summary
Study start date: August 1, 2022
Actual date on which the first participant was enrolled.Chronic functional constipation (FC) is a common condition that can negatively impact quality of life, often associated with psychological issues like anxiety and depression. A specific type within Traditional Chinese Medicine (TCM) is 'Yang deficiency type' FC, which is understood as a deficiency of Yang Qi leading to slowed metabolism and weakened large intestine motility. This study explores whether warm needling moxibustion at specific acupoints, Tianshu (ST25) and Guanyuan (CV4), can provide superior and sustained benefits compared to electroacupuncture alone for this condition. The trial aims to offer clinical evidence on the efficacy of warm needling for a well-defined TCM condition, potentially improving care for those suffering from chronic functional constipation. This single-center, randomized controlled trial involves 60 participants diagnosed with Yang deficiency type chronic FC. Participants are divided into two groups: an experimental group receiving warm needling, and a control group receiving electroacupuncture. For the warm needling group, sterile needles are inserted at Tianshu (ST25) and Guanyuan (CV4), then a moxa stick is attached and ignited, conducting heat down the needle to deeper tissues. For the electroacupuncture group, needle insertion is identical, but the needles are connected to an electroacupuncture device delivering a dense-sparse wave. Both groups receive treatment every other day, three times weekly, for four weeks. The primary outcome is the change from baseline in the Constipation Severity Score (CSS) at week 4 and month 6, with secondary outcomes including changes in TCM syndrome score, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and Patient Assessment of Constipation Quality of Life (PAC-QOL) scale.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
the First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, ChinaOpen the First Affiliated Hospital of Henan University of Chinese Medicine in Google Maps